X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pulmonary hypertension (12) 12
index medicus (9) 9
humans (8) 8
respiratory system (8) 8
cardiac & cardiovascular systems (7) 7
female (7) 7
male (7) 7
middle aged (7) 7
care and treatment (6) 6
hypertension, pulmonary - drug therapy (6) 6
pulmonary/respiratory (6) 6
adult (5) 5
aged (5) 5
hypertension, pulmonary - physiopathology (5) 5
pulmonary arterial hypertension (5) 5
riociguat (5) 5
survival (5) 5
treatment outcome (5) 5
antihypertensive agents - administration & dosage (4) 4
arterial-hypertension (4) 4
clinical trials (4) 4
diagnosis (4) 4
drug administration schedule (4) 4
outcomes (4) 4
pyrazoles - administration & dosage (4) 4
pyrimidines - administration & dosage (4) 4
administration, inhalation (3) 3
chronic thromboembolic pulmonary hypertension (3) 3
endarterectomy (3) 3
hypertension (3) 3
hypertension, pulmonary - mortality (3) 3
iloprost - administration & dosage (3) 3
iloprost - adverse effects (3) 3
long-term extension (3) 3
pulmonary arteries (3) 3
soluble guanylate cyclase stimulator (3) 3
surgery (3) 3
young adult (3) 3
adolescent (2) 2
aged, 80 and over (2) 2
assaigs clínics (2) 2
chronic disease (2) 2
double-blind (2) 2
double-blind method (2) 2
drug therapy (2) 2
early access study (2) 2
endothelin receptor antagonists - administration & dosage (2) 2
exercise (2) 2
hipertensió pulmonar (2) 2
idiopathic pulmonary arterial hypertension (2) 2
inhaled iloprost (2) 2
international prospective registry (2) 2
japanese (2) 2
lung diseases (2) 2
malalties de l'aparell respiratori (2) 2
medical colleges (2) 2
meeting abstracts (2) 2
mortality (2) 2
natriuretic peptide, brain - blood (2) 2
open-label (2) 2
predictors (2) 2
pulmonary (2) 2
pulmonary embolism - complications (2) 2
pulmonary embolism - drug therapy (2) 2
pulmonary embolism - mortality (2) 2
pyrazoles - adverse effects (2) 2
pyrimidines - adverse effects (2) 2
quality of life (2) 2
registry (2) 2
respiratory organs diseases (2) 2
risk factors (2) 2
therapy (2) 2
time (2) 2
transplantation (2) 2
vasodilator agents - administration & dosage (2) 2
vasodilator agents - adverse effects (2) 2
walking (2) 2
1506 (1) 1
1st-line bosentan (1) 1
610 medical sciences medicine (1) 1
610 medicine & health (1) 1
aerosolized prostacyclin (1) 1
analog (1) 1
antihypertensive agents - adverse effects (1) 1
antihypertensive agents - pharmacology (1) 1
antihypertensive agents - therapeutic use (1) 1
asian continental ancestry group (1) 1
biological markers (1) 1
camphor (1) 1
cardiology (1) 1
chest-2 (1) 1
clinic for pneumology (1) 1
clinical endpoint definitions (1) 1
clinical study (1) 1
clinical trial (1) 1
clinical worsening (1) 1
continuous intravenous epoprostenol (1) 1
cut-off (1) 1
delivery aad system (1) 1
disease (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2002, Volume 347, Issue 5, pp. 322 - 329
Journal Article
Journal Article
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2017, Volume 128, pp. 50 - 56
Abstract Background Riociguat was well tolerated and improved exercise and functional capacity in patients with pulmonary arterial hypertension (PAH) and... 
Pulmonary/Respiratory | Soluble guanylate cyclase stimulator | Riociguat | Pulmonary hypertension | Clinical study | TRIAL | CARDIAC & CARDIOVASCULAR SYSTEMS | RESPIRATORY SYSTEM | PREDICTORS | OPEN-LABEL | HEMOPTYSIS | OUTCOMES | INTERNATIONAL PROSPECTIVE REGISTRY | Enzyme Activators - pharmacology | Antihypertensive Agents - pharmacology | Soluble Guanylyl Cyclase - metabolism | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Male | Enzyme Activators - administration & dosage | Adult | Female | Hypertension, Pulmonary - drug therapy | Walk Test - statistics & numerical data | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Hypertension, Pulmonary - mortality | Pulmonary Embolism - complications | Pyrimidines - administration & dosage | Treatment Outcome | Pyrimidines - pharmacology | Pulmonary Embolism - mortality | Disease-Free Survival | Pyrazoles - administration & dosage | Enzyme Activators - adverse effects | Pyrimidines - adverse effects | Pulmonary Embolism - drug therapy | Aged | Exercise - physiology | Clinical trials | Respiratory agents | Cardiology | Endothelin | Hypertension | Edema | Physical training | Health | Cut-off | Pulmonary arteries | Medical services | Rhinopharyngitis | Fatal | Patients | Survival | Walking | Hemoptysis | Functional anatomy | Functional morphology | Safety | Thromboembolism
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2010, Volume 104, Issue 5, pp. 731 - 740
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 04/2018, Volume 37, Issue 4, pp. 513 - 519
The Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL) risk score (RRS) calculator was developed using data derived from the REVEAL... 
risk assessment | soluble guanylate cyclase stimulator | right heart failure | pulmonary arterial hypertension | survival | clinical worsening | SURGERY | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | PULMONARY ARTERIAL-HYPERTENSION | TRANSPLANTATION | LONG-TERM EXTENSION | RESPIRATORY SYSTEM | DISEASE MANAGEMENT REVEAL | OUTCOMES | REGISTRY
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2017, Volume 36, Issue 4, pp. S20 - S20
The REVEAL risk score (RRS) was developed to predict survival in patients with pulmonary arterial hypertension (PAH), based on multiple patient... 
Surgery | Medical colleges | Care and treatment | Pulmonary hypertension | Risk factors
Journal Article
Circulation Journal, ISSN 1346-9843, 2016
Background:Inhaled iloprost is approved for pulmonary arterial hypertension (PAH) in many countries. IBUKI was a phase III, non-randomized, open-label study of... 
Idiopathic pulmonary arterial hypertension | Pulmonary arterial hypertension | Japanese | Pulmonary hypertension
Journal Article
Pulmonary Circulation, ISSN 2045-8932, 09/2013, Volume 3, Issue 3, pp. 721 - 722
We thank Ms. Deborah McCollister for her feedback on our recent article titled “Updating clinical endpoint definitions.” McCollister judiciously points out... 
Letter to the Editor | RESPIRATORY SYSTEM | CARDIAC & CARDIOVASCULAR SYSTEMS
Journal Article
Heart Asia, ISSN 1759-1104, 05/2016, Volume 8, Issue 1, pp. 74 - 82
ObjectivePATENT-1 and CHEST-1 were pivotal, international phase III trials assessing riociguat for pulmonary arterial hypertension (PAH) and chronic... 
Journal Article
Journal Article